eISSN: 1897-4252
ISSN: 1731-5530
Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2022
vol. 19
 
Share:
Share:
Original paper

Transatrial-transpulmonary correction of tetralogy of Fallot: experience of a developing country

Kouassi Antonin Souaga
1
,
Rebecca  Bonny
1
,
Eric Koutoua Katche
1
,
Aime Yoboua KiriouaKamenan
1
,
Anderson Kwadjau Amani
1
,
Jean Calaire Degré
1
,
Randolph Gnamien Niava
1
,
Joseph Kouamé
2
,
Paul Yapo
2
,
Flavien Kouassi Kendja
1

1.
Cardiovascular Surgery Department, the Abidjan Heart Institute, Abidjan, Ivory Coast
2.
Anesthesia and Intensive Care Department, the Abidjan Heart Institute, Abidjan, Ivory Coast
Kardiochirurgia i Torakochirurgia Polska 2022; 19 (3): 130-134
Online publish date: 2022/10/08
Article file
Get citation
 
PlumX metrics:
 

Introduction

Tetralogy of Fallot is the most common cyanotic congenital heart disease [13]. It represents 7% to 15% of all congenital heart diseases [3, 4]. The treatment is essentially surgical. It consists of a complete cure or a palliative intervention.

The first complete cures were possible thanks to cardiopulmonary bypass. The surgical approach was the right ventriculotomy. But this approach was responsible in the long term for a progressive alteration of the right ventricular function with the risk of sudden death by ventricular arrhythmia [5, 6]. The disadvantage of this approach has led to the development of other approaches, notably the transatrial-transpulmonary approach.

Aim

The aim of our study is to report the immediate and long-term operative results of the complete cure of tetralogy of Fallot by the transatrial-transpulmonary approach through our experience.

Material and methods

Our work is a retrospective and prospective study concerning 19 patients with tetralogy of Fallot who underwent a complete cure by the trans-atrial-trans-pulmonary approach between April 2009 and October 2010 in our institution. There were 10 female and 9 male patients. The mean age at surgery was 7.4 ±4.52 years with extremes of 3 and 19 years. The mean body surface area was 0.85 ±0.29 (extremes 0.52 and 1.59). The different preoperative characteristics are summarized in Table I. No patient received a systemic-pulmonary shunt before the complete cure. Three patients received preoperative hemodilution.

Table I

Preoperative characteristics of patients

Preoperative dataValues
Age [years]7.4 ±4.52 (3–19)
Sex ratio0.9
Weight [kg]22.1 ±11.04 (11–53)
Body surface area0.85 ±0.29 (0.52–1.59)
Symptoms:
 Dyspnea of effort11 (57.90)
 Digital clubbing14 (73.70)
 Cyanosis8 (42.10)
 Thoracic deformation2 (10.50)
 Squatting1 (5.30)
Biology:
 Oxygen saturation90.52 ±7.29% (71–95%)
 Hematocrit52.31 ±10.16% (31.1–73.6)
Radiology:
 CTI0.54 ±0.07 (0.44–0.67)
Obstruction on the pulmonary pathway:
 Infundibulum19 (100)
 Pulmonary ring14 (73.7)
 Trunk of the pulmonary artery10 (52.6)
 Left pulmonary artery8 (42.1)
 Right pulmonary artery7 (32.8)
NAKATA index209.25 ±75.60 mm2/BSA (116–332)
Associated anomalies:
 Patent ductus arteriosus4 (21)
 Atrial septal defect4 (21)

[i] CTI – cardiothoracic index, BSA – body surface area.

Surgical management

All patients were operated on under cardiopulmonary bypass (CPB). It was performed in normothermia (37°C) in 14 (73.70%) patients, in moderate hypothermia (> 32°C) in 4 (21%) patients and in deep hypothermia (20°C) in 1 (5.30%) case. Ten patients were operated on in partial hemodilution and the other 9 in total hemodilution. Myocardial protection was provided after aortic clamping by warm blood cardioplegia solution in 13 (68.4%) cases and by cold crystalloid cardioplegia solution in 6 (31.6%) cases. The mean duration of CPB was 125.57 ±31.65 minutes with extremes of 91 minutes and 232 minutes. The mean duration of aortic clamping was 78.42 ±20.09 minutes with extremes of 47 minutes and 138 minutes. The approach to the lesions was the transatrial-transpulmonary route. By right atriotomy through the tricuspid valve, we performed parietal and septal band resection in all patients. Then closure of the ventricular septal defect (VSD) was performed with an autologous pericardial patch previously treated with 0.6% glutaraldehyde. After arteriotomy, the diameter of the pulmonary tract was measured (at the infundibulum, annulus, and branches) with a Hegar candle, corresponding to the theoretical diameter of the pulmonary tract. Additional strip resection was performed when necessary through the pulmonary artery. When the annulus and/or branches were hypoplastic, an incision was made with patch enlargement. All patients received pulmonary artery enlargement with an autologous pericardial patch previously treated with 0.60% glutaraldehyde. These patches were all infundibulo-pulmonary, which required a short infundibulotomy (< 1 cm). This infundibulotomy did not allow resection of the muscle strips or closure of the VSD. We performed an enlargement at the level of: the pulmonary infundibulum and annulus (trans annulus) in 17 (89.5%) cases; the pulmonary infundibulum, annulus, and pulmonary artery trunk (AP trunk) in 1 (6.7%) case; the pulmonary infundibulum, annulus, AP trunk, and bifurcation in 1 (6.70%) case.

The four persistent ducts were ligated, with the duct being sectioned before the start of extracorporeal circulation. The four atrial septal defects and the 4 patent foramen ovales were closed by direct suture. Pulmonary valve stenosis required commissurotomy.

Statistical analysis

The data were analyzed descriptively and analytically using Epi Info software, Version 6. Statistical tests were performed on the same software and we used the Student’s t test. The accepted significance level was 0.05. Quantitative data were described by the mean and standard deviation while qualitative variables were described by proportions.

Results

Average extubation time was 13.23 hours (3 to 72 hours). The average length of stay in the surgical intensive care unit (ICU) was 3.82 ±1.81 days (range 2 to 8 days). Two patients died in the ICU (10.5% mortality). They were a young man of 19 years old, who died on postoperative day (POD) 9 following a poly visceral failure and a 3-year-old girl who died on POD 10 of low cardiac output.

The immediate postoperative morbidity was marked at the cardiac level by 3 cases of right heart failure, 2 cases of low cardiac output and 1 case of transient rhythm disorder. We observed 7 cases of pleuropulmonary complications, including 4 cases of pleurisy, 2 cases of bronchopneumonia and 1 case of atelectasis (Table II). Hemodynamically, the mean pressure gradient between the right ventricle and the pulmonary artery (RV-PA pressure gradient) in the postoperative period was 18.77 ±11.95 mm Hg, with extremes of 0 and 44 mm Hg. The mean postoperative right ventricle/left ventricle pressure ratio was 0.47 ±0.10 with extremes of 0.28 and 0.73.

Table II

Complications observed in the immediate postoperative period

ComplicationsNumber (n)Percentage (%)
Right heart failure317.60
Low cardiac output211.80
Pericardial effusion423.50
Thrombosis of the right jugular vein15.90
Cardiac rhythm disorder15.90
Cardiac conduction disorder:17100
 IRBBB529.40
 CRBBB1164.70
 CRBBB + transient CAVB15.90

[i] IRBBB – incomplete right bundle branch block, CAVB – complete atrioventricular block, CRBBB – complete right bundle branch block.

Cardiac echocardiography performed before discharge showed residual restrictive VSD in 5 (29.4%) patients and mild residual stenosis in 4 (23.5%) patients. Pulmonary insufficiency was also noted in 12 (70.6%) cases and tricuspid insufficiency in 7 (41.2%) cases. The importance of these different leaks is specified in Table III.

Table III

Distribution according to postoperative valve insufficiency of patients with tetralogy of Fallot operated by the transatrial-transpulmonary route

Degree of leakagePulmonary insufficiencyTricuspid insufficiency
Grade194
Grade 232
Grade 301
Grade 400
Total127

The average postoperative hospital stay was 12.7 ±5.07 days with extremes of 8 and 29 days. The long-term evolution after an average follow-up was 11.43 ±0.81 years with extremes of 10 years and 12.75 years. No patients were lost to follow-up.

At the last check-up all patients were asymptomatic: 14 (8.40%) patients at NYHA stage I and 3 (17.60%) patients at stage II.

On radiography the mean CTI of the patients followed was 0.56 ±0.03 (range: 0.51 to 0.62.) The mean CTI of the patients was 0.54 preoperatively and then 0.56 during follow-up. The observed difference was non-significant with a p = 0.49.

Three (17.60%) patients presented with rhythm disorders such as ventricular extrasystole. Ten patients had complete right bundle branch block, 5 patients had incomplete right bundle branch block. One patient presented a left anterior hemi block and a complete right bundle branch block.

On ultrasound monitoring, the left ventricular ejection fraction was 0.65 ±0.03 with extremes of 0.61 and 0.71. During follow-up the RV/LV pressure gradient was 23.13 ±14.18 mm Hg with extremes of 4.48 and 49.7. This postoperative RV-PA pressure gradient increased from 18.8 immediately postoperatively to 23.1 during follow-up. The observed difference was non-significant with a p = 0.3816.

Seven patients had minimal residual lesions: 5 (31.3%) cases of pulmonary stenosis and 2 (12.5%) cases of residual ventricular septal defect. In addition, during the follow-up, 8 (47.1%) cases of grade I tricuspid insufficiency were noted. The number of patients who had pulmonary insufficiency remained stable without worsening. One case of complication was observed: it was a rhythm disorder of supraventricular tachycardia that required an external electric shock and then an anti-arrhythmic: amiodarone with a good evolution. This patient presented 2.5 years later with junctional tachycardia at 260 bpm after voluntary discontinuation of his treatment. The disorders improved under antiarrhythmic treatment.

No deaths were observed during follow-up.

Discussion

The transatrial-transpulmonary approach has been used more recently in our institution compared to the ventricular approach [7]. This approach, by avoiding a large ventriculotomy, makes it possible to preserve the integrity and contractile function of the right ventricle in the long term. This route may require a short incision over the infundibulum, but this incision leaves the body of the RV free to act as a pump [7]. Because of the significant stenosis at the annulus, trans-annular patches were placed in all patients. The rate of use of trans-annular patches varies according to the series, from 60% to 79% [69].

This correction technique allows closure of the ventricular septal defect only through the right atrial pathway [6]. This closure was achieved in all patients with an autologous pericardial patch. Several studies have been performed to compare the operative results of the transventricular and transatrial-transpulmonary approaches [6, 1014]. These studies show that early mortality by the transventricular route varies between 1% and 30% with a reoperation rate of 10–20% [1012], whereas by the transatrial-transpulmonary route a lower mortality rate is found: between 0 and 2% with a reoperation rate of 0 to 5% [6, 12].

The mortality rate in our study appears to be high (10.5%) compared to those reported in the literature. However, these deaths concern only 2 patients: the size of our relatively small sample could explain the differences observed.

The transatrial-transpulmonary route entails the risk of several complications that are not specific to this route. The cardiac complications are dominated by conduction disorders: 100% of cases of right bundle branch block (complete and incomplete). These conduction abnormalities are related to the path of the His bundle and its branches. They run along the inferior margin of the ventricular septal defect and can be injured at the time of closure [15]. Thus, all authors report a high rate of branch block after surgical cure of T4F from 91% to 100% [16, 17]. However, serious conduction disorders, in particular atrioventricular blocks, which require a permanent device, have not been observed.

The postoperative functional result was satisfactory, but differed according to the approach used. For similar follow-up, the percentage of patients (operated by the TA-TP route) at NHYA stage I is 100% [6, 8], while for patients operated on by the ventricular route the percentage is between 82% and 91% [17, 18]. These results seem to confirm that by the TA-TP route, right ventricular function is better preserved.

Residual lesions are mainly located in the LV ejection pathway, where they are almost obligatory [2]: residual stenosis and pulmonary insufficiency, but also residual VSD.

The removal of the obstacle on the pulmonary pathway is the most important element in the complete cure of T4F which conditions the prognosis [17]. The VD-AP gradient should ideally be below 25 mm Hg, but it is greater in about 30% of cases [19, 20]. A pulmonary gradient between 25 and 50 mm Hg is tolerable, but above 50 mm Hg there is a significant risk of late mortality and morbidity, i.e. exercise intolerance and rhythm disorders. In this case, a re-operation to widen the pulmonary pathway is necessary [2].

In our study, the mean RV-PA gradient was 18.77 mm Hg and the RV/LV ratio was 0.47. These operative results obtained by this route are satisfactory with a non-significant gradient. They testify to the removal of the obstacle in the pulmonary tract.

Some authors consider that it is difficult to completely resect the muscle bands by the transatrial-transpulmonary route. This pathway would therefore be responsible for a residual obstacle [6, 20]. They confirm that this approach is responsible for a high incidence of re-operation for residual obstruction. However, it is preferable to the risk of pulmonary valve replacement (with unavoidable multiple reoperations), late dilatation of the right ventricle and the risk of death following the ventricular route [8]. However, several studies in which the cure is performed by the transatrial-transpulmonary route give good operative results [5, 6, 21]. Pulmonary valve insufficiency (PVI) is very frequent and is observed in about 60% of cases [2]. In the majority of cases, it is impossible to completely correct the staged narrowing without inducing pulmonary valve insufficiency [2]. The placement of a transannular patch during the operation leaves part of the orifice unguarded. This fact is of course the main factor responsible for these regurgitations. The evaluation of the pulmonary insufficiency is difficult. Regurgitation is mild in the majority of cases and is considered to be well tolerated for many years [2]. This observation is also made in our study; indeed in the immediate postoperative period we had 12 cases of PI (70, 60%) with a majority at grade 1 (9 cases). During the follow-up, the pulmonary insufficiencies remained stable without hemodynamic repercussions. The observation of residual shunts is usual after VSD repair and their rate varies between 5% and 39% [22, 23]. The rate in our study was within this range. However, the majority of residual VSDs are minimal and disappear in the long term. Only rarely do they require re-intervention [24, 25]. This was the case in our study. Five patients presented a minimal shunt in the immediate postoperative period and three of the five disappeared with time. These shunts remained minimal and well tolerated. No surgical revision was necessary as observed by some authors [5, 9, 20].

Limitations of the study: The retrospective nature of the study with the bias of data recruitment. The size of the sample: a small sample of 19 patients. This figure does not reflect the frequency of the pathology but testifies to the difficulty of access to care for the population. A comparative study would seem necessary to better appreciate the advantages of the transatrial-transpulmonary route over the ventricular route.

Conclusions

Complete cure of tetralogy of Fallot by the transatrial-transpulmonary approach is associated with low morbidity and mortality in our experience. There is a satisfactory long-term operative outcome in followed survivors: asymptomatic patients at last check-up, little or no residual pulmonary stenosis, residual pulmonary insufficiency present but minimal and minimal residual shunt. Long-term results are satisfactory.

Disclosure

The authors report no conflict of interest.

References

1 

Romeo JLR, Etnel JRG, Takkenbreg JJM, Roos-Hesselink JW, Helbing WA, Van de Woestijne P, Bogers AJ, Mokhles M. Outcome of surgical repair of tetralogy of Fallot: a sytematic review an meta-analysis. J Thorac Cardiovasc Surg 2020; 159: 220-236.

2 

Friedli B. Tétralogie de Fallot. In: Encycl Med Chir: cardiologie. Elsevier, Paris 2002; 9.

3 

Guikahué MK, Yangni-Angate H, Kramoh KE, Kangah KM, Koffi J, Ake-traboulsi E, Harding-Tanon D, Demine B, Yapobi Y, Metras D, Chauvet J. Approche thérapeutique de la tétralogie de Fallot en Afrique noire subsaharienne: à propos de 130 cas hospitalisés à l’institut de cardiologie d’Abidjan Côte d’Ivoire. Afr Ann Thorac Cardiovasc Surg 2008; 3: 39-44.

4 

Ojji DB, Babalola AO, Falase AO. Uncorrected tetralogy of fallot in a 25-year old Nigerian African. Clin Med Insights Case Rep 2011; 4: 21-23.

5 

Airan B, Choudhary SK, Kumar HV, Talwar S, Dhareshwar J, Juneja R, Kothari SS, Saxena A, Venugopal P. Total transatrial correction of tetralogy of Fallot: no outflow patch technique. Ann Thorac Surg 2006; 82: 1316-1321.

6 

Giannopoulos NM, Chatzis AK, Karros P, Zavaropoulos P, Papagiannis J, Rammos S, Kirvassilis GV, Sarris GE. Early results after transatrial/transpulmonary repair of tetralogy of Fallot. Eur J Cardiothorac Surg 2002; 22: 582-586.

7 

Padalino MA, Vida VL, Stellin G. Transatrial-transpulmonary repair of tetralogy of Fallot. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2009; 48-53.

8 

Luijten LW, van den Bosch E, Duppen N, Tanke R, Roos-Hesselink J, Nijveld A, van Dijk A, Bogers AJ, van Domburg R, Helbing WA. Long-term outcomes of transatrial-transpulmonary repair of tetralogy of Fallot. Eur J Cardiothorac Surg 2015; 47: 527-534.

9 

Reddy VM, Liddicoat JR, McElhinney DB, Brook MM, Stanger P, Hanley FL. Routine primary repair of tetralogy of Fallot in neonates and infants less than three months of age. Ann Thorac Surg 1995; 60 (6 Suppl): S592-S596.

10 

Alexiou C, Mahmoud H, Al-Khaddour A, Gnanapragasam J, Salmon AP, Keeton BR, Monro JL. Outcome after repair of tetralogy of Fallot in the first year of life. Ann Thorac Surg 2001; 71: 494-500.

11 

Bacha EA, Scheule AM, Zurakowski D, Erickson LC, Hung J, Lang P, Mayer JE Jr, del Nido PJ, Jonas RA. Long-term results after early primary repair of tetralogy of Fallot. J Thorac Cardiovasc Surg 2001; 122: 154-161.

12 

de Ruijter FT, Weenink I, Hitchcock FJ, Meijboom EJ, Bennink GB. Right ventricular dysfunction and pulmonary valve replacement after correction of tetralogy of Fallot. Ann Thorac Surg 2002; 73: 1794-1800.

13 

Faidutti B, Christenson JT, Beghetti M, Friedli B, Kalangos A. How to diminish reoperation rates after initial repair of tetralogy of Fallot? Ann Thorac Surg 2002; 73: 96-101.

14 

Stellin G, Milanesi O, Rubino M, Michielon G, Bianco R, Moreolo GS, Boneva R, Sorbara C, Casarotto D. Repair of tetralogy of Fallot in the first six months of life: transatrial versus transventricular approach. Ann Thorac Surg 1995; 60 (6 Suppl): S588-S591.

15 

Friedli B. Troubles du rythme après chirurgie des cardiopathies congénitales Quelles investigations? Quels traitements? [Arrhythmia after surgery for congenital cardiopathies. What studies? What treatment?]. Arch Mal Coeur Vaiss 1996; 89: 351-357.

16 

Calder AL, Barratt-Boyes BG, Brandt PW, Neutze JM. Postoperative evaluation of patients with tetralogy of Fallot repaired in infancy. Including criteria for use of outflow patching and radiologic assessment of pulmonary regurgitation. J Thorac Cardiovasc Surg 1979; 77: 704-720.

17 

Krammoh KE. Chirurgie de la tétralogie de Fallot à l’institut de cardiologie d’Abidjan: Résultats [Thèse Med]. Abidjan: UFR des sciences médicales 1998.

18 

Wu Q. Indication and technique of total correction of tetralogy of Fallot in 228 patients. Ann Thorac Surg 1996; 61: 1769-1774.

19 

Oberhänsli I, Schorderet D, Laufer D, Rouge JC, Faidutti B, Friedli B. Tétralogie de Fallot: évolution à long terme après une opération correctrice [Tetralogy of Fallot: long-term evolution following corrective surgery]. Schweiz Med Wochenschr 1986; 116: 1613-1616.

20 

Ruzyllo W, Nihill MR, Mullins CE, McNamara DG. Hemodynamic evaluation of 221 patients after intracardiac repair of tetralogy of Fallot. Am J Cardiol 1974; 34: 565-576.

21 

Kaushal SK, Radhakrishanan S, Dagar KS, Iyer PU, Girotra S, Shrivastava S, Iyer KS. Significant intraoperative right ventricular outflow gradients after repair for tetralogy of Fallot: to revise or not to revise? Ann Thorac Surg 1999; 68: 1705-1712.

22 

Bol-Raap G, Weerheim J, Kappetein AP, Witsenburg M, Bogers AJ. Follow-up after surgical closure of congenital ventricular septal defect. Eur J Cardiothorac Surg 2003; 24: 511-515.

23 

Kangah KM, Souaga KA, Amani KA, Kirioua KA, Kendja KF, Guikahue MK. Résultats du traitement chirurgical des communications inter ventriculaires en Côte d’Ivoire. A propos de 87 cas. Rev Afr Chir 2008; 11: 5-8.

24 

Dodge-Khatami A, Knirsch W, Tomaske M, Prêtre R, Bettex D, Rousson V, Bauersfeld U. Spontaneous closure of small residual ventricular septal defects after surgical repair. Ann Thorac Surg 2007; 83: 902-905.

25 

Navabi Shirazi MA, Ghavanini AA, Sajjadi S. Early postoperative results after total correction of tetralogy of fallot in older patients: is primary repair always justified? Pediatr Cardiol 2001; 22: 238-241.

Copyright: © 2022 Polish Society of Cardiothoracic Surgeons (Polskie Towarzystwo KardioTorakochirurgów) and the editors of the Polish Journal of Cardio-Thoracic Surgery (Kardiochirurgia i Torakochirurgia Polska). This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.